RankingsPricing
  1. US-listed companies
  2. T2 Biosystems, Inc.
  3. Financials
  4. Retained earnings

T2 Biosystems, Inc.TTOO

Market cap
$420.86K
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Dec 31, 2023-584+9.38%
Dec 31, 2022-534+13.13%
Dec 31, 2021-472+11.63%
Dec 31, 2020-423+12.45%
Dec 31, 2019-376+18.60%
Dec 31, 2018-317+19.18%
Dec 31, 2017-266+30.65%
Dec 31, 2016-204+36.81%
Dec 31, 2015-149+43.72%
Dec 31, 2014-104

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)